Apogenix raises 7.5M euros; Cornerstone buys Cardiokine; Xoma nabs $10M loan;

@FierceBiotech: Bleak forecast puts Lilly's R&D game plan to the test. Will this change Lechleiter's approach? Article | Follow @FierceBiotech

@JohnCFierce: Germany's Apogenix raises €7.5M for glioblastoma drug work. Release | Follow @JohnCFierce

@RyanMFierce: Here's my own take on @Quintiles new digital patient unit, with insights from the group's chief: Story | Follow @RyanMFierce

@FierceMedDev: FDA orders safety evaluation of vaginal mesh--Bloomberg. Article | Follow @FierceMedDev

> Germany's Apogenix GmbH has banked a 7.5 million euro round led by dievini Hopp BioTech holding GmbH. The biotech is working on a new treatment for glioblastoma. Release

> Cornerstone Therapeutics has struck a deal to buy Cardiokine for a modest down payment of $1 million and up to $147 million based on the future success of the biotech's heart drugs. News

> Xoma ($XOMA) has lined up a $10 million loan from GE Capital to help fund clinical trials of its lead drug. Story

> Abbott Biotech Ventures has made an unspecified investment in NeuroGenetic Pharmaceuticals, which is working on Alzheimer's. Release

Pharma News

@FiercePharma: Pennsylvania appeals court affirms $45M in Prempro damages; Pfizer says it'll go to state supreme court. Report | Follow @FiercePharma

> Pfizer gains ground in India, but Abbott still rules. Article

> Lilly surprises with lower-than-expected 2012 forecast. News

> FDA restricts some antibiotics in livestock. Item

Vaccine News

> Study: Most girls who get HPV vax say they see need to practice safe sex. Item

> FDA approves Pfizer's Prevnar 13 for adults over 50. Article

> Vaccine combo shows early promise against AIDS. Story

> Preclinical data in hand, Tetragenetics seeks partners for vaccine platform. Report

> GSK's genital herpes vaccine gets disappointing results. Article

> Argentina fines GSK $93K for Synflorix vaccine trial. News

Manufacturing News

> Novartis adds OTC drug plant to GMP fix list. News

> AZ starts work on record-setting plant in China. Item

> Report: Big Pharma finds Indian collaborations costly. Story

> Pharma fires, pollution targeted in India. More

> Hospira enters angry-investor phase of remediation. Article

> Expired-drug take vs. toss debate gets new vetting. Story

And Finally... After gaining encouraging primate data for an experimental AIDS vaccine developed by J&J ($JNJ) and the U.S. military, investigators say they're ready to start testing it in human studies. Report

Suggested Articles

MicuRx nabbed $7.78 million from a nonprofit focused on antimicrobial resistance to push its third antimicrobial program into human trials.

The FDA has handed Scholar Rock a rare pediatric disease designation voucher, which can allow the biotech a speedy review of its SMA med.

The FDA has placed a phase 1/2 trial of Passage Bio’s GM1 gene therapy on clinical hold pending further assessment of the risk of its delivery device.